Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|January 9, 2019
Systemic and Tissue Inflammation in Juvenile Dermatomyositis: From Pathogenesis to the Quest for Monitoring ToolsJudith Wienke, Claire T Deakin, Lucy R Wedderburn, et al.
Arthritis Research & Therapy|April 16, 2020
Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patientsRaquel Campanilho-Marques, Claire T Deakin, Stefania Simou, et al.
Rheumatology Advances in Practice|September 20, 2021
A survey to understand the feelings towards and impact of COVID-19 on the households of juvenile dermato myositis patients from a parent or carer perspectiveMeredyth Grace Llewellyn Wilkinson, Wing Wu, Kathryn O'Brien, et al.
Internal Medicine Journal|November 27, 2023
Comparative effectiveness of etanercept originator and biosimilar for treating rheumatoid arthritis: implications for cost-savingsClaire T Deakin, Geoffrey O Littlejohn, Hedley Griffiths, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 18, 2018
Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural ModelingClaire T Deakin, Raquel Campanilho-Marques, Stefania Simou, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|August 9, 2024
Post-discharge pharmacotherapy in people with atrial fibrillation hospitalized for acute myocardial infarction: an Australian cohort study 2018-22Claire T Deakin, Juliana de Oliveira Costa, David Brieger, et al.
ACR Open Rheumatology|June 12, 2023
Comparative Effectiveness of First-Line Baricitinib in Patients With Rheumatoid Arthritis in the Australian OPAL Data SetSabina Ciciriello, Geoffrey Littlejohn, Tamas Treuer, et al.
Nucleic Acids Research|July 12, 2014
Impact of next-generation sequencing error on analysis of barcoded plasmid libraries of known complexity and sequenceClaire T Deakin, Jeffrey J Deakin, Samantha L Ginn, et al.
Seminars in Arthritis and Rheumatism|June 6, 2022
Adalimumab or etanercept as first line biologic therapy in enthesitis related arthritis (ERA) - a drug-survival single centre study spanning 10 yearsMuhammad Ra Shipa, Nicola Heyer, Rashid Mansoor, et al.
Nature Communications|December 10, 2020
Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admissionHannah Peckham, Nina M de Gruijter, Charles Raine, et al.
Pageof 4